Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 11-Apr-24 7:44 PM View:  | Peregrine Pharmaceuticals I... (CDMO) | 09-Apr-24 | Option Exercise | 3,208 | -- | -- | 5% 63.27K to 66.48K | |
| 11-Jan-24 7:39 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 10-Jan-24 | Option Sale | 1,346 | $6.17 | $8,304.82 | (2%) 64.61K to 63.27K | |
| 11-Jan-24 7:39 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 09-Jan-24 | Option Exercise | 3,208 | -- | -- | 5% 61.41K to 64.61K | |
| 03-Jan-24 7:56 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 29-Dec-23 | Acquisition (other) | 892 | $5.53 | $4,928.30 | 1% 60.52K to 61.41K | |
| 11-Oct-23 7:59 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 10-Oct-23 | Option Sale | 1,141 | $9.20 | $10,496.70 | (2%) 61.66K to 60.52K | |
| 11-Oct-23 7:59 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 09-Oct-23 | Option Exercise | 3,207 | -- | -- | 5% 58.45K to 61.66K | |
| 12-Jul-23 7:38 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 11-Jul-23 | Option Sale | 5,015 | $13.86 | $69,504.90 | (8%) 63.46K to 58.45K | |
| 12-Jul-23 7:38 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 10-Jul-23 | Option Exercise | 14,291 | -- | -- | 29% 49.17K to 63.46K | |
| 11-Jul-23 8:15 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 10-Jul-23 | Option Sale | 687 | $13.77 | $9,460.33 | (1%) 49.86K to 49.17K | |
| 11-Jul-23 8:15 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 09-Jul-23 | Option Exercise | 1,958 | -- | -- | 4% 47.9K to 49.86K | |
| 03-Jul-23 6:52 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 30-Jun-23 | Acquisition (other) | 927 | $11.46 | $10,621.60 | 2% 46.98K to 47.9K | |
| 30-Jun-23 8:13 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 30-Jun-23 | Option Sale | 1,280 | $13.49 | $17,267.20 | (3%) 48.26K to 46.98K | |
| 30-Jun-23 8:13 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 29-Jun-23 | Option Sale | 2,377 | $12.70 | $30,191.50 | (5%) 50.63K to 48.26K | |
| 30-Jun-23 8:13 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 28-Jun-23 | Option Exercise | 10,513 | -- | -- | 26% 40.12K to 50.63K | |
| 02-May-23 10:00 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 01-May-23 | Option Exercise | 25,000 | $9.87 | $246,750.00 | 62% 40.12K to 65.12K | |
| 02-May-23 10:00 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 01-May-23 | Planned Option Sale | 25,000 | $17.91 | $447,853.00 | (38%) 65.12K to 40.12K | |
| 11-Apr-23 7:43 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 10-Apr-23 | Option Sale | 736 | $19.80 | $14,570.40 | (2%) 40.85K to 40.12K | |
| 11-Apr-23 7:43 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 09-Apr-23 | Option Exercise | 1,958 | -- | -- | 5% 38.9K to 40.85K | |
| 11-Jan-23 7:46 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 10-Jan-23 | Option Sale | 1,150 | $14.44 | $16,606.80 | (3%) 40.05K to 38.9K | |
| 11-Jan-23 7:46 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 09-Jan-23 | Option Exercise | 1,957 | -- | -- | 5% 38.09K to 40.05K | |
| 03-Jan-23 7:38 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 30-Dec-22 | Acquisition (other) | 815 | $11.70 | $9,539.17 | 2% 37.27K to 38.09K | |
| 11-Oct-22 8:28 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 09-Oct-22 | Option Exercise | 1,957 | -- | -- | 6% 35.32K to 37.27K | |
| 12-Jul-22 8:35 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 10-Jul-22 | Option Exercise | 14,290 | -- | -- | 68% 21.03K to 35.32K | |
| 12-Jul-22 8:35 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 09-Jul-22 | Option Exercise | 697 | -- | -- | 3% 20.33K to 21.03K | |
| 11-Jul-22 7:42 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 07-Jul-22 | Option Exercise | 5,350 | -- | -- | 36% 14.98K to 20.33K | |
| 01-Jul-22 7:31 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 30-Jun-22 | Acquisition (other) | 450 | $12.97 | $5,836.95 | 3% 14.53K to 14.98K | |
| 21-Jun-22 7:33 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 17-Jun-22 | Option Exercise | 6,428 | $3.29 | $21,148.10 | 79% 8.1K to 14.53K | |
| 12-Apr-22 7:58 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 11-Apr-22 | Option Sale | 368 | $18.56 | $6,830.82 | (4%) 8.47K to 8.1K | |
| 12-Apr-22 7:58 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 09-Apr-22 | Option Exercise | 696 | -- | -- | 9% 7.78K to 8.47K | |
| 22-Mar-22 7:50 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 22-Mar-22 | Option Exercise | 3,152 | $3.29 | $10,370.10 | 41% 7.78K to 10.93K | |
| 22-Mar-22 7:50 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 22-Mar-22 | Planned Option Sale | 3,152 | $22.03 | $69,447.10 | (29%) 10.93K to 7.78K | |
| 22-Mar-22 7:50 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 21-Mar-22 | Option Exercise | 1,974 | $3.29 | $6,494.46 | 25% 7.78K to 9.75K | |
| 22-Mar-22 7:50 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 21-Mar-22 | Planned Option Sale | 1,974 | $22.03 | $43,482.50 | (20%) 9.75K to 7.78K | |
| 22-Mar-22 7:50 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 18-Mar-22 | Option Exercise | 1,302 | $3.29 | $4,283.58 | 17% 7.78K to 9.08K | |
| 22-Mar-22 7:50 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 18-Mar-22 | Planned Option Sale | 1,302 | $22.01 | $28,660.00 | (14%) 9.08K to 7.78K | |
| 11-Feb-22 6:08 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 10-Feb-22 | Option Exercise | 6,429 | $3.29 | $21,151.40 | 83% 7.78K to 14.2K | |
| 11-Feb-22 6:08 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 10-Feb-22 | Planned Option Sale | 6,429 | $22.14 | $142,328.00 | (45%) 14.2K to 7.78K | |
| 11-Jan-22 8:22 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 10-Jan-22 | Market Option Sale | 351 | $21.58 | $7,574.16 | (4%) 8.13K to 7.78K | |
| 11-Jan-22 8:22 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 09-Jan-22 | Option Exercise | 697 | -- | -- | 9% 7.43K to 8.13K | |
| 05-Jan-22 7:56 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 03-Jan-22 | Option Exercise | 20,675 | $12.74 | $263,476.00 | 278% 7.43K to 28.1K | |
| 05-Jan-22 7:56 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 03-Jan-22 | Market Option Sale (Planned) | 20,675 | $27.65 | $571,672.00 | (74%) 28.1K to 7.43K | |
| 29-Dec-21 7:23 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 27-Dec-21 | Market Sale (Planned) | 6,829 | $30.27 | $206,689.00 | (48%) 14.26K to 7.43K | 3% |
| 16-Dec-21 9:36 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 15-Dec-21 | Option Exercise | 6,429 | $3.29 | $21,151.40 | 45% 14.26K to 20.69K | |
| 16-Dec-21 9:36 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 15-Dec-21 | Market Option Sale (Planned) | 6,429 | $24.57 | $157,945.00 | (31%) 20.69K to 14.26K | |
| 12-Oct-21 5:38 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 11-Oct-21 | Market Option Sale | 349 | $22.37 | $7,807.51 | (2%) 14.61K to 14.26K | |
| 12-Oct-21 5:38 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 09-Oct-21 | Option Exercise | 696 | -- | -- | 5% 13.91K to 14.61K | |
| 14-Jul-20 9:25 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 13-Jul-20 | Market Option Sale | 3,683 | $6.88 | $25,339.00 | (35%) 10.51K to 6.83K | |
| 14-Jul-20 9:25 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 10-Jul-20 | Option Exercise | 10,512 | -- | -- | 100% 0 to 10.51K |